Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
IRB or ethics approval is required for human studies
Americans spent $40 billion on appetite-suppressing drugs in 2024, a figure that is projected to triple by 2030, according to Grand View Research
The patients unique facial features determine whether the upper lip should be emphasized, whether the lip border needs definition, and how much projection is appropriate
Secure your order before stock depletes
The active ingredient (semaglutide or tirzepatide) is the same, but the formulation may differ slightly from the brand-name version
It remains in active Phase 3 development, with Eli Lilly targeting an NDA filing later in 2026 based on the TRIUMPH-1 and TRIUMPH-4 data reported so far
US$ 20.03
US$ 26.74
US$ 22.95
US$ 23.33
